BIOA BioAge Labs, Inc.
$5.47▲ +9.62%
Healthcare
Other
Volume 1.11M
Avg Volume (10D) 743.7K
Key Metrics & Fundamentals
Market Cap
$251.06M
P/E Ratio
–
Div Yield
0.00%
52W Range
4.81 - 25.96
% vs 50 MA
-28.55%
% vs 200 MA
-65.89%
RSI-14
36.6
MACD Histogram
+0.1200
Beta (1Y vs SPY)
1.79
Free Cash Flow
-$19.59M
Gross Rev
$2.45M
Gross Profit
$2.45M
EBITDA
-$25.83M
COGS
–
Operating Exp
$31.78M
Operating Income
-$29.33M
EBIT
-$29.33M
Pretax Income
-$26.10M
Net Income
-$26.10M
EPS (Diluted)
-0.58
Price & Volume History
Loading chart…
Recent News
BioAge Labs, Deep Origin Collaborate on AI-Driven Drug Discovery
MT Newswires · Oct 14, 2026 8:42 AM ET
Deep Origin Announces Multi-Target AI-Driven Drug Discovery Collaboration with BioAge Labs; Validated Hits Confirmed against First Target
GlobeNewswire · Oct 14, 2026 8:00 AM ET
BioAge Labs' Lead Drug Faces Uncertain Path as Data Looms, UBS Says
MT Newswires · Oct 12, 2026 1:02 PM ET
BioAge Labs to Present at Upcoming Investor Conferences
GlobeNewswire · Sep 25, 2026 4:30 PM ET
BioAge Labs Doses First Patient in Phase 2 Trial of BGE-102 in Diabetic Macular Edema
MT Newswires · Sep 8, 2026 10:01 AM ET
BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema
GlobeNewswire · Sep 8, 2026 8:00 AM ET
BioAge Labs to Present at Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 8:00 AM ET
Number of shares and votes in BioArctic AB (publ) as of August 31, 2026
PR Newswire · Aug 31, 2026 11:57 AM ET
Number of shares and votes in BioArctic AB (publ) as of August 31, 2026
PR Newswire · Aug 31, 2026 11:56 AM ET
BioAge Labs, Inc. (BIOA) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 5, 2026 8:35 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BIOA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.